Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing

Journal of Cosmetic and Laser Therapy

Volumn 6, Issue 3, 2004, Pages 145-148

  Yamauchi, Paul S ^b   Lask, Gary P ^b   Lowe, Nicholas J ^a  

^a Clinical Research Specialists   (United States)

^b NONE

Author keywords

Botox; Laser resurfacing; Rhytides

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; SODIUM CHLORIDE;

AGING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ERBIUM YAG LASER; FEMALE; HUMAN; INJECTION; LOW LEVEL LASER THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; REJUVENATION; SKIN PIGMENTATION; ULTRAVIOLET RADIATION; WRINKLE;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; FACIAL MUSCLES; FEMALE; HUMANS; INJECTIONS; LASER SURGERY; MUSCLE CONTRACTION; RHYTIDOPLASTY; SKIN AGING;

EID: 10644266873     PISSN: 14764172     EISSN: None     Source Type: Journal    
DOI: 10.1080/14764170410023767     Document Type: Article

References (15)

1. Fagien S. BOTOX for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 1999; 103: 701-13.
2. Pierard GE, Lapier CM. The microanatomical basis of facial frown lines. Arch Dermatol 1989; 125: 1090-2.
3. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186-94.
4. Simpson LL. Botulinum toxin: a deadly poison sheds its negative images. Ann Intern Med 1996; 125: 616-17.
5. Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002; 46: 840-9.
6. Blitzer A, Brin MF, Keen JS, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993; 119: 1018-22.
7. Carruthers A, Carruthers JDA. The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles. Cosmet Dermatol 1994; 7: 11-15.
8. Guryuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg 1994; 93: 913-18.
9. Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994; 94: 94-9.
10. Carruthers A, Carruthers JDA. Botulinum toxin in the treatment of glabellar frown lines and other facial wrinkles In: Jankovic J, Halet M, eds. Therapy with botulinum toxin. Marcel Dekker: New York, 1994: 577-95.
11. Blitzer A, Binder WJ, Jonathan E, et al. The management of hyperfunctional facial lines with botulinum toxin: a collaborative study of 210 injections sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997; 123: 389-92.
12. Pribitkin EA, Greco TM, Goode RL, et al. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch Otolaryngol Head Neck Surg 1997; 123: 321-6.
13. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996; 34: 788-97.
14. Lowe NJ, Lask G, Yamauchi P, et al. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol 2002; 47: 834-40.
15. Lowe NJ. Botulinum toxin: combination treatments for the face and neck. In Lowe NJ, editor. Textbook of Facial Rejuvenation. Martin Dunitz, London. 2002. p. 157-70.